| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1044899828 |
| P356 | DOI | 10.1046/J.1523-1755.1999.00773.X |
| P698 | PubMed publication ID | 10594797 |
| P5875 | ResearchGate publication ID | 12706211 |
| P50 | author | Martin G Larson | Q37390385 |
| Daniel Levy | Q88264418 | ||
| Peter Wilson | Q89854449 | ||
| P2093 | author name string | Parfrey PS | |
| Evans JC | |||
| Culleton BF | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cardiovascular disease | Q389735 |
| P304 | page(s) | 2214-2219 | |
| P577 | publication date | 1999-12-01 | |
| P1433 | published in | Kidney International | Q6404823 |
| P1476 | title | Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency | |
| P478 | volume | 56 |
| Q56970799 | 2007 ESH‐ESC Guidelines for the management of arterial hypertension |
| Q56970511 | 2013 ESH/ESC Guidelines for the management of arterial hypertension |
| Q21261435 | A genome-wide association for kidney function and endocrine-related traits in the NHLBI's Framingham Heart Study |
| Q34457191 | A multi-marker approach to predict incident CKD and microalbuminuria |
| Q44603637 | A population-based study of the incidence and outcomes of diagnosed chronic kidney disease |
| Q35865224 | A review of risk factors for stroke in patients with chronic kidney disease |
| Q46394339 | Accuracy of retinal changes in predicting microalbuminuria among elderly hypertensive patients: a cross-sectional study from a teaching hospital in South India. |
| Q36733550 | Adherence to a healthy lifestyle and all-cause mortality in CKD |
| Q37783877 | Albuminuria: all you need to predict outcomes in chronic kidney disease? |
| Q73292237 | An Association between Aortic Pulse Wave Velocity, Blood Pressure and Chronic Inflammation in ESRD Patients on Peritoneal Dialysis |
| Q36560971 | Anemia and cardiovascular disease in diabetic nephropathy |
| Q40308406 | Antiproliferation effect of the uremic toxin para‑cresol on endothelial progenitor cells is related to its antioxidant activity |
| Q57750160 | Ascorbic acid lowers central blood pressure and asymmetric dimethylarginine in chronic kidney disease |
| Q46891103 | Assessment of glomerular filtration rate in addition to albuminuria is important in managing type II diabetes |
| Q31073301 | Association between moderate renal insufficiency and cardiovascular events in a general population: Tehran lipid and glucose study |
| Q36950146 | Association of Endothelial and Mild Renal Dysfunction With the Severity of Left Ventricular Hypertrophy in Hypertensive Patients |
| Q44689239 | Association of atherosclerotic coronary artery disease and pulse pressure with renal disease progression |
| Q36570007 | Association of carotid intima-media thickness with cardiovascular risk factors and patient outcomes in advanced chronic kidney disease: the RRI-CKD study |
| Q36317731 | Association of coronary artery disease and chronic kidney disease in Lebanese population |
| Q51110244 | Association of glomerular filtration rate with slow coronary flow in patients with normal to mildly impaired renal function. |
| Q37700890 | Association of renal function with clinical parameters and conditions in a longitudinal population-based epidemiological study |
| Q82099172 | Association of renal function with the ambulatory arterial stiffness index and pulse pressure in hypertensive patients |
| Q57101788 | Blood pressure elevation in hemodialysis patients after the Great East Japan Earthquake |
| Q44716954 | C-reactive protein and microalbuminuria differ in their associations with various domains of vascular disease |
| Q33504418 | CKD classification based on estimated GFR over three years and subsequent cardiac and mortality outcomes: a cohort study |
| Q36440902 | Cardiac enzymes, renal failure and renal transplantation |
| Q35509396 | Cardiac remodelling and functional alterations in mild-to-moderate renal dysfunction: comparison with healthy subjects |
| Q86899285 | Cardiac valve calcification is associated with presence and severity of coronary artery disease in patients with pre-dialysis chronic kidney disease |
| Q33728260 | Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative |
| Q37831154 | Cardiovascular Complications in CKD Patients: Role of Oxidative Stress. |
| Q35107192 | Cardiovascular Mortality in End-Stage Renal Disease |
| Q40633486 | Cardiovascular Risk Evaluated With the Use of Heartscore in Kidney Transplant Recipients-Three Years of Follow-up. |
| Q35983544 | Cardiovascular disease among hispanics and non-hispanics in the chronic renal insufficiency cohort (CRIC) study |
| Q38025185 | Cardiovascular disease in chronic kidney disease: untying the Gordian knot |
| Q79761741 | Cardiovascular events following renal transplantation: role of traditional and transplant-specific risk factors |
| Q46188104 | Cardiovascular events in patients with hidden renal failure detected by equations of glomerular filtration |
| Q37557361 | Cardiovascular risk factors in patients with chronic kidney disease |
| Q36161264 | Cardiovascular risk in chronic renal disease and transplantation prevention and management |
| Q36306246 | Cardiovascular risk in patients with mild renal insufficiency: implications for the use of ACE inhibitors |
| Q37449550 | Change in cardiovascular risk factors with progression of kidney disease |
| Q86553722 | Chapter 4: Other complications of CKD: CVD, medication dosage, patient safety, infections, hospitalizations, and caveats for investigating complications of CKD |
| Q86553726 | Chapter 5: Referral to specialists and models of care |
| Q92153368 | Chronic Kidney Disease Has a Graded Association with Death and Cardiovascular Outcomes in Stable Coronary Artery Disease: An Analysis of 21,911 Patients from the CLARIFY Registry |
| Q53180851 | Chronic kidney disease and metabolic syndrome in a general Korean population: the Third Korea National Health and Nutrition Examination Survey (KNHANES III) Study. |
| Q37089713 | Chronic kidney disease and postoperative mortality: a systematic review and meta-analysis |
| Q57414635 | Chronic kidney disease and risk of incident myocardial infarction and all-cause and cardiovascular disease mortality in middle-aged men and women from the general population |
| Q34687362 | Chronic kidney disease and the risk of heart failure in men |
| Q36839471 | Chronic kidney disease as a predictor of cardiovascular disease (from the Framingham Heart Study) |
| Q46891348 | Chronic kidney disease as a risk factor for coronary artery disease in Chinese with type 2 diabetes |
| Q35030634 | Chronic kidney disease in octogenarians |
| Q34257447 | Chronic kidney disease itself is a causal risk factor for stroke beyond traditional cardiovascular risk factors: a nationwide cohort study in Taiwan |
| Q35117574 | Chronic kidney disease: issues and establishing programs and clinics for improved patient outcomes |
| Q44481322 | Chronic renal insufficiency in children: the 2001 Annual Report of the NAPRTCS. |
| Q51606892 | Chronic renal insufficiency, cardiovascular disease and mortality in women: a causal relationship or coincidence? |
| Q35019817 | Chronic renal ischemia: implications for cardiovascular disease risk |
| Q41843005 | Clinical epidemiology of reduced kidney function among elderly male fishing and agricultural population in Taipei, Taiwan |
| Q37074691 | Clinical imaging for prevention: directed strategies for improved detection of presymptomatic patients with undetected atherosclerosis--Part I: Clinical imaging for prevention |
| Q36359500 | Clinical use and pathogenetic basis of laboratory tests for the evaluation of primary arterial hypertension |
| Q36704257 | Clues to cardiovascular risk: an office-based approach |
| Q77456421 | Comparison of outcomes after percutaneous coronary revascularization with stents in patients with and without mild chronic renal insufficiency |
| Q35850963 | Compliance Index, a Marker of Peripheral Arterial Stiffness, may Predict Renal Function Decline in Patients with Chronic Kidney Disease. |
| Q44231095 | Contribution of glomerular filtration rate to 10-year cardiovascular and mortality risk among hypertensive adults: Tehran lipid and glucose study |
| Q35657151 | Coronary plaque progression of non-culprit lesions after culprit percutaneous coronary intervention in patients with moderate to advanced chronic kidney disease: intravascular ultrasound and integrated backscatter intravascular ultrasound study. |
| Q48028435 | Correlation of the Volume Control Parameters With Health Related Quality of Life in Renal Transplant Patients |
| Q35581538 | Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from the global registry of acute coronary events (GRACE). |
| Q44787244 | Creatinine clearance and signs of end-organ damage in primary hypertension. |
| Q24806091 | Creatinine clearance versus serum creatinine as a risk factor in cardiac surgery |
| Q39180221 | Cystatin C and Cardiac Measures in Children and Adolescents With CKD. |
| Q54531871 | Cystatin C identifies cardiovascular risk better than creatinine-based estimates of glomerular filtration in middle-aged individuals without a history of cardiovascular disease. |
| Q35746107 | Cystatin C is associated with inflammation but not atherosclerosis in systemic lupus erythematosus |
| Q43261354 | Declining renal function after myocardial infarction predicts poorer long-term outcome |
| Q34519960 | Decreased GFR estimated by MDRD or Cockcroft-Gault equation predicts incident CVD: the strong heart study |
| Q51367146 | Decreased glomerular filtration rate is a significant and independent risk for in-hospital mortality in Japanese patients with acute myocardial infarction: report from the Hokkaido acute myocardial infarction registry. |
| Q44419285 | Decreased renal function is a strong risk factor for cardiovascular death after renal transplantation1,2 |
| Q34039715 | Development and reproducibility of a computed tomography-based measurement of renal sinus fat |
| Q34609759 | Diabetic kidney disease and the cardiorenal syndrome: old disease, new perspectives |
| Q36345531 | Dialysis patients and cardiovascular problems: Can technology help solve the complex equation? |
| Q36315162 | Dialysis patients and cardiovascular problems: can technology solve the complex equation? |
| Q51958627 | Difference in long-term prognostic value of renal function between ischemic and non-ischemic mild heart failure. |
| Q64977285 | Diosgenin glucoside protects against myocardial injury in diabetic mice by inhibiting RIP140 signaling. |
| Q44369531 | Distribution and determinants of serum creatinine in the general population: the Hordaland Health Study |
| Q44505470 | Do associations with C-reactive protein and extent of coronary artery disease account for the increased cardiovascular risk of renal insufficiency? |
| Q47363893 | Dyslipidaemia in nephrotic syndrome: mechanisms and treatment |
| Q46047725 | Effect of chronic kidney disease on individual and population medical expenditures in the Japanese population |
| Q48948394 | Effect of renal impairment on the pharmacokinetics, pharmacodynamics, and safety of apixaban |
| Q33588706 | Effect of statins on cardiovascular events in patients with mild to moderate chronic kidney disease: a systematic review and meta-analysis of randomized clinical trials |
| Q51672088 | Effects of extracellular acid stimulation on rat vascular smooth muscle cell in Gas6/Axl or PI3K/Akt signaling pathway. |
| Q37416887 | Effects of phosphate binder therapy on vascular stiffness in early-stage chronic kidney disease. |
| Q85036918 | Effects of renal dysfunction on cardiovascular events in diabetic patients with hypertension: Challenge-DM Study subgroup analysis |
| Q33910812 | Empiric potassium supplementation and increased survival in users of loop diuretics |
| Q37824822 | Epidemiology and outcome of the cardio-renal syndrome |
| Q37698861 | Epidemiology of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference |
| Q34870809 | Estimated GFR associates with cardiovascular risk factors independently of measured GFR. |
| Q47135452 | Estimated Glomerular Filtration Rate, Proteinuria, and Risk of Cardiovascular Diseases and All-cause Mortality in Diabetic Population: a Community-based Cohort Study |
| Q51122936 | Estimated glomerular filtration rate is associated with both arterial stiffness and N-terminal pro-brain natriuretic peptide in newly diagnosed hypertensive patients. |
| Q37406965 | Evalution of in vitro effect of flavonoids on human low-density lipoprotein carbamylation |
| Q41922310 | Evolution of chronic kidney disease in patients with systemic lupus erythematosus over a long-period follow-up: a single-center inception cohort study |
| Q44325502 | FOSIDIAL: a randomised placebo controlled trial of the effects of fosinopril on cardiovascular morbidity and mortality in haemodialysis patients. Study design and patients' baseline characteristics |
| Q37637391 | Gene regulation in the vascular endothelium: why epigenetics is important for the kidney |
| Q59590081 | Glomerular Filtration Rate and Coronary Artery Disease Burden in Patients with Acute Coronary Syndrome |
| Q35141731 | Glomerular filtration rate and proteinuria: association with mortality and renal progression in a prospective cohort of a community-based elderly population |
| Q82042158 | Glomerular filtration rate is related to severity of obstructive coronary artery disease in patients undergoing coronary angiography |
| Q57455386 | Gut Microbial Product Predicts Cardiovascular Risk in Chronic Kidney Disease Patients |
| Q44134298 | Haemodialysis-unresponsive blood pressure: cardiovascular mortality predictor? |
| Q22306347 | Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee |
| Q22306345 | Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association |
| Q29547236 | Heart disease and stroke statistics--2011 update: a report from the American Heart Association |
| Q34479128 | Heart-kidney interaction: epidemiology of cardiorenal syndromes |
| Q43424992 | High prevalence of undiagnosed kidney disease in those presenting with troponin positive acute coronary syndrome |
| Q44243763 | How to decrease cardiovascular mortality in renal transplant recipients |
| Q37813472 | Hypertension, left ventricular hypertrophy and chronic kidney disease |
| Q46375255 | Hypertensive women with the metabolic syndrome are at risk of renal insufficiency more than men in general population |
| Q36973766 | Hypoalbuminaemia--a marker of cardiovascular disease in patients with chronic kidney disease stages II-IV. |
| Q39141325 | Identification of a Proteinaceous Component in the Leaf of Moringa Oleifera lam. with Effects on High Serum Creatinine |
| Q47162070 | Impact of Renal Functional/Morphological Dynamics on the Calcification of Coronary and Abdominal Arteries in Patients with Chronic Kidney Disease. |
| Q51192626 | Impact of glomerular filtration rate on clinical outcomes after carotid artery revascularization in 11,832 patients from the CARE registry. |
| Q37315041 | Impact of renal dysfunction on clinical outcomes of acute coronary syndrome |
| Q46210108 | Incident CKD after Radical or Partial Nephrectomy |
| Q33637899 | Increased cardiovascular risk associated with reduced kidney function |
| Q92878090 | Indoxyl sulfate impairs valsartan-induced neovascularization |
| Q40601088 | Influence of concurrent renal dysfunction on outcomes of patients with acute coronary syndromes and implications of the use of glycoprotein IIb/IIIa inhibitors |
| Q34604651 | Influence of progressive renal dysfunction in chronic heart failure |
| Q38829813 | Inhibition of H3K9 histone methyltransferase G9a attenuates renal fibrosis and retains klotho expression |
| Q83381153 | Inhibition of eNOS phosphorylation mediates endothelial dysfunction in renal failure: new effect of asymmetric dimethylarginine |
| Q44976978 | Insulin resistance and pancreatic beta-cell function in patients with hypertensive kidney disease |
| Q46842389 | Inverse relationship between ambulatory arterial stiffness index and glomerular filtration rate in arterial hypertension. |
| Q44199205 | Is renal insufficiency an atherogenic state? Reflections on prevalence, incidence, and risk |
| Q93054064 | Kidney cachexia or protein-energy wasting in chronic kidney disease: facts and numbers |
| Q37248468 | Kidney function and risk of cardiovascular disease and mortality in women: a prospective cohort study |
| Q37042040 | Lanthanum carbonate reduces phosphorus burden in patients with CKD stages 3 and 4: a randomized trial |
| Q33791650 | Left ventricular mass progression despite stable blood pressure and kidney function in stage 3 chronic kidney disease. |
| Q78899068 | Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community |
| Q35607759 | Lipid-related residual risk and renal function for occurrence and prognosis among patients with first-event acute coronary syndrome and normal LDL cholesterol |
| Q33871665 | Living kidney donation: the outcomes for donors |
| Q37258874 | Long-term renal function and cardiovascular disease risk in obese kidney donors |
| Q89970155 | Macroscopic hematuria as a risk factor for hypertension in ageing people with hemophilia and a family history of hypertension |
| Q44393048 | Managing comorbidities of inflammatory rheumatic diseases |
| Q34582124 | Markers of increased cardiovascular risk in patients with chronic kidney disease. |
| Q50902373 | Mean platelet volume is independently associated with renal dysfunction in stable coronary artery disease. |
| Q40171911 | Metabolic syndrome and chronic kidney disease in a Southern Chinese population |
| Q33795888 | Metabolic syndrome is independently associated with a mildly reduced estimated glomerular filtration rate: a cross-sectional study |
| Q57562754 | Metabolic syndrome status over 2 years predicts incident chronic kidney disease in mid-life adults: a 10-year prospective cohort study |
| Q34595173 | Metabolic syndrome, chronic kidney disease, and cardiovascular disease: a dynamic and life-threatening triad. |
| Q92531945 | Micro RNA-192 Is Negatively Associated With Cardiovascular Events Among Wait-Listed Potential Kidney Transplant Recipients on Hemodialysis Over a 5-year Follow-up Period |
| Q33888381 | Microalbuminuria is a predictor of chronic renal insufficiency in patients without diabetes and with hypertension: the MAGIC study |
| Q36589494 | Microalbuminuria is independently associated with arterial stiffness and vascular inflammation but not with carotid intima-media thickness in patients with newly diagnosed type 2 diabetes or essential hypertension |
| Q44583585 | Mild renal insufficiency and risk of congestive heart failure in men and women > or =70 years of age. |
| Q51824398 | Mild renal insufficiency is associated with reduced coronary flow in patients with non-obstructive coronary artery disease. |
| Q51535218 | Mildly decreased glomerular filtration rate is associated with poor coronary collateral circulation in patients with coronary artery disease. |
| Q36191289 | Minor abnormalities of renal function: a situation requiring integrated management of cardiovascular risk |
| Q53583788 | Modified LDLs induce proliferation-mediated death of human vascular endothelial cells through MAPK pathway. |
| Q33844756 | Mortality following operations for lower extremity peripheral arterial disease |
| Q24794480 | Nadroparine calcium or enoxaparine in acute coronary syndrome patients suffering renal insufficiency: The nadroparin versus enoxaparin (NaVe) study design |
| Q41464060 | Neck Circumference as a Predictive Indicator of CKD for High Cardiovascular Risk Patients |
| Q33810673 | No Relationship between Serum and Salivary β2- Microglobulin Levels in A Sample of Adult Diabetic Men with Chronic Kidney Disease without Renal Replacement Therapy |
| Q38046611 | Of heart and kidney: a complicated love story |
| Q36863889 | Overlap between common genetic polymorphisms underpinning kidney traits and cardiovascular disease phenotypes: the CKDGen consortium |
| Q38084417 | Oxidative stress in patients with cardiovascular disease and chronic renal failure |
| Q43551410 | P-cresol, but not p-cresylsulphate, disrupts endothelial progenitor cell function in vitro |
| Q47550895 | Patient-Reported Outcomes in Patients with Chronic Kidney Disease and Kidney Transplant-Part 1. |
| Q36789995 | Patterns and predictors of short-term death after emergency department discharge |
| Q46613207 | Plasma levels of AGE peptides in type 1 diabetic patients are associated with serum creatinine and not with albumin excretion rate: possible role of AGE peptide-associated endothelial dysfunction |
| Q40342900 | Pleural effusion as a result of chronic renal ischemia. |
| Q35642540 | Predominant effect of kidney disease on mortality in Pima Indians with or without type 2 diabetes |
| Q50099911 | Premature Coronary Artery Disease and Early Stage Chronic Kidney Disease |
| Q92406599 | Presence of Carotid Plaque Is Associated with Rapid Renal Function Decline in Patients with Type 2 Diabetes Mellitus and Normal Renal Function |
| Q44492732 | Prevalence and treatment of cardiovascular disease and traditional risk factors in Australian adults with renal insufficiency. |
| Q36612817 | Prevalence of chronic kidney diseases and its determinants among perimenopausal women in a rural area of North India: A community-based study |
| Q43885926 | Prevalence of chronic renal failure in primary care |
| Q35687619 | Prevalence of vascular risk factors and vascular disease in predialysis chronic renal failure |
| Q35669317 | Progression of coronary artery calcification and cardiac events in patients with chronic renal disease not receiving dialysis. |
| Q35553269 | Prospective trials on anemia of chronic disease: The Trial to Reduce Cardiovascular Events with Aranesp® Therapy (TREAT) |
| Q35024794 | Protein-energy wasting and mortality in chronic kidney disease |
| Q36721454 | Proteinuria and Reduced Estimated Glomerular Filtration Rate Independently Predict Risk for Acute Myocardial Infarction: Findings from a Population-Based Study in Keelung, Taiwan. |
| Q34683498 | Proteinuria, impaired kidney function, and adverse outcomes in people with coronary disease: analysis of a previously conducted randomised trial |
| Q34962156 | Proteinuria: an underappreciated risk factor in cardiovascular disease |
| Q35134165 | Pulse-Wave Analysis of Optic Nerve Head Circulation Is Significantly Correlated with Kidney Function in Patients with and without Chronic Kidney Disease. |
| Q37299015 | RADAR - A randomised, multi-centre, prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with haemodynamically relevant atherosclerotic renal artery stenosis |
| Q56970710 | Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document |
| Q37240652 | Reduced Kidney Function Is Associated With Cardiometabolic Risk Factors, Prevalent and Predicted Risk of Cardiovascular Disease in Chinese Adults: Results From the REACTION Study |
| Q74587371 | Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction |
| Q93609219 | References |
| Q58737866 | Refined characterization of the association between kidney function and mortality in patients undergoing cardiac catheterization |
| Q36043978 | Relationship between Estimated Glomerular Filtration Rate and Cardiovascular Mortality in a Japanese Cohort with Long-Term Follow-Up |
| Q37488984 | Relationship between Serum N-Terminal Pro-Brain Natriuretic Peptide Level and Left Ventricular Dysfunction and Extracellular Water in Continuous Ambulatory Peritoneal Dialysis Patients |
| Q35009842 | Relationship between chronic kidney disease and risk of coronary heart disease in Korean men |
| Q35436297 | Relationship of chronic kidney disease to cardiovascular death and myocardial infarction following coronary stenting. |
| Q44993831 | Relevance of chronic kidney disease and cardiovascular prognosis in arterial hypertension |
| Q34222274 | Renal Ischemia Regulates Marinobufagenin Release in Humans |
| Q34824937 | Renal dysfunction as a cardiovascular risk factor |
| Q33297377 | Renal function and risk of coronary heart disease in general populations: new prospective study and systematic review |
| Q34459987 | Renal function: the Cinderella of cardiovascular risk profile |
| Q46382796 | Renal hypertensive target organ damage--new evidence emerges in diabetics and smokers |
| Q44127410 | Renal impairment and coronary collaterals in patients with acute coronary syndrome |
| Q43723152 | Renal insufficiency and cardiovascular events in postmenopausal women with coronary heart disease |
| Q36667145 | Renal insufficiency and mortality in patients with known or suspected coronary artery disease |
| Q46955620 | Renal insufficiency and the risk of infection from pacemaker or defibrillator surgery |
| Q44411143 | Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals |
| Q58046912 | Renal morphology assessed by ultrasound in relation to central haemodynamics and body fat |
| Q34738544 | Renal protection by antihypertensive therapy |
| Q51513501 | Renal scintigraphy predicts global cardiovascular risk in hypertensive subjects with normal serum creatinine levels. |
| Q41444409 | Renoprotective effects of febuxostat in hyperuricemic patients with chronic kidney disease: a parallel-group, randomized, controlled trial |
| Q35107210 | Risk Factors for Coronary Artery Disease in Patients with Renal Failure |
| Q38120646 | Role of dyslipidemia in patients with chronic kidney disease |
| Q36799689 | Selective improvement in renal function preserved remote myocardial microvascular integrity and architecture in experimental renovascular disease |
| Q92564509 | Serum Creatinine and Occurrence and Severity of Coronary Artery Disease |
| Q43965678 | Serum creatinine is associated with coronary disease risk even in the absence of metabolic disorders. |
| Q82729773 | Serum fibrinogen levels are an independent predictor of mortality in patients with chronic kidney disease (CKD) stages 3 and 4 |
| Q34451969 | Serum uric acid levels are associated with polymorphisms in the SLC2A9, SF1, and GCKR genes in a Chinese population |
| Q34577344 | Significant differences when using creatinine, modification of diet in renal disease, or cystatin C for estimating glomerular filtration rate in ICU patients |
| Q35985860 | Skin autofluorescence and the association with renal and cardiovascular risk factors in chronic kidney disease stage 3. |
| Q38230258 | Stroke and cerebrovascular diseases in patients with chronic kidney disease |
| Q36478002 | Subnormal Estimated Glomerular Filtration Rate Strongly Predict Incident Cardiovascular Events in Type 2 Diabetic Chinese Population With Normoalbuminuria |
| Q58719644 | TGF-β1 promotes expression of fibrosis-related genes through the induction of histone variant H3.3 and histone chaperone HIRA |
| Q57174517 | The Incidence and Pathophysiology of the Obesity Paradox: Should Peritoneal Dialysis and Kidney Transplant Be Offered to Patients with Obesity and End-Stage Renal Disease? |
| Q38584122 | The Kidney-Vascular-Bone Axis in the Chronic Kidney Disease-Mineral Bone Disorder |
| Q34790359 | The burden of chronic kidney disease in long-term liver transplant recipients. |
| Q83259164 | The characteristics of new semi-quantitative method for diagnosing proteinuria by using random urine samples |
| Q74587430 | The effect of intracoronary radiation for the treatment of recurrent in-stent restenosis in patients with chronic renal failure |
| Q42147370 | The effects of low-dose nepsilon-(carboxymethyl)lysine (CML) and nepsilon-(carboxyethyl)lysine (CEL), two main glycation free adducts considered as potential uremic toxins, on endothelial progenitor cell function |
| Q57105044 | The great East Japan earthquake: blood pressure control in patients with chronic kidney disease |
| Q35985715 | The microvasculature in chronic kidney disease. |
| Q36980849 | The prevalence of chronic kidney disease in a primary care setting: a Swiss cross-sectional study |
| Q35105833 | The prognostic significance of renal dysfunction in patients with chronic systolic heart failure |
| Q37859780 | The rise of hemodialysis machines: new technologies in minimizing cardiovascular complications |
| Q35905894 | The role of a parental history of Balkan endemic nephropathy in the occurrence of BEN: a prospective study |
| Q36581425 | Therapy insight: management of cardiovascular disease in the renal transplant recipient |
| Q36488717 | Traditional and emerging cardiovascular and renal risk factors: an epidemiologic perspective. |
| Q44901632 | Uric acid measurement improves prediction of cardiovascular mortality in later life. |
| Q92211885 | Vaccine Against PCSK9 Improved Renal Fibrosis by Regulating Fatty Acid β-Oxidation |
| Q34052928 | Validating a case definition for chronic kidney disease using administrative data |
| Q43493575 | Value and level of circulating endothelial progenitor cells, angiogenesis factors and mononuclear cell apoptosis in patients with chronic kidney disease |
| Q27021802 | Vascular effects of exercise training in CKD: current evidence and pathophysiological mechanisms |
| Q86593765 | WITHDRAWN: Correlation of Volume Control Parameters With Health-Related Quality of Life in Renal Transplant Patients |
| Q37837005 | What we know about oxidative stress in patients with chronic kidney disease on dialysis--clinical effects, potential treatment, and prevention. |
| Q34803864 | [Hypertension and the kidney]. |
| Q83879580 | [Renal function in heart failure patients. Prognostic influence and therapeutic implications] |
| Q82734949 | [What has changed in the current management of hypertension from the renal point of view?] |
Search more.